State-of-the-art Facilities: Designed With Quality In Mind
SCA features state-of-the-art production facilities in both Arkansas and Connecticut.
Our 90,000 square foot production facility located in Windsor, CT opened in November 2017. This cutting edge facility features progressive design elements to facilitate quicker turnaround times and enhance our customers’ experience.
“We are very pleased that as we continue our geographical expansions, in both Arkansas and Connecticut, we can partner with AECD to solidify and expand the operations of our legacy operations,” said Milton Boyer CEO of SCA Pharma. “Ensuring that hospitals have all of the readily available sterile injectable pharmaceuticals they need to properly treat and care for patients is more critical today than ever before,” said Milton Boyer, CEO of SCA Pharma. “The demand for SCA products continues to increase, and we are committed to meeting that need safely, efficiently and reliably. Our new construction will position us to expand our capacity and make products even more accessible to hospitals.”
SCA Pharma to Expand Production Facility in Little Rock
SCA Pharma, an FDA-registered outsourcing facility, today announced that it will expand its operations in Little Rock. SCA…
SCA Pharma to Expand Production Facility for Compounded Sterile Medications
SCA Pharma, an FDA-registered outsourcing facility, plans to expand its sterile pharmaceutical manufacturing facility in Windsor, CT, by…
Meeting the challenge of abrupt product mix changes and social distancing during COVID-19
Michelle Wood, vice president of sales and marketing, shares how SCA Pharma’s sales team is adapting to market…